Publication dates

All regions

Prostate Cancer Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, more »


 
1-20 of about 5 900 reports for Prostate Cancer

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

InterGenetics Incorporated - Strategic SWOT Analysis Review

InterGenetics Incorporated - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Risk. The comapny also has a range of research pipeline of predictive tests for other cancers such as ovarian, colon, and prostate cancer. Intergenetics is headquartered in oklahoma, the us ...

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

... By local market factors. Some highlights from the digest include: - global prostate cancer therapeutics market has good commercial potential - physicians in china prescribe less ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Influenza partnering in numberstop influenza partnering deals by valuemost active influenza partnering companies10. prostate cancerprostate cancer partnering in numberstop prostate cancer partnering ...

Prostate Cancer Partnering 2009-2014

Prostate Cancer Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... This data driven report contains over 160 links to online copies of actual prostate cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners ...

 Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Reasons to buy - complete pipeline intelligence and complete understanding over therapeutics development for metastatic hormone refractory prostate cancer - identify the relationship between ...

 Metastatic Prostate Cancer-Pipeline Insights, 2014

Metastatic Prostate Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under metastatic prostate cancer. This report provides information ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Castration resistant, androgen-independent) prostate cancer pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline products ...

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Hdc-sn-38 - drug profile 199drugs to antagonize cxcr1/2 for bladder and prostate cancer - drug profile 201suramin hexasodium - drug profile 202sx-mtr1 - drug profile 204qbecp ssi - drug ...

Prostate Cancer Drug Pipeline Update 2014

Prostate Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To alternatives. Establishing the optimal timing of antihormonal therapy will provide the key to market growth.There are today 350 companies plus partners developing 415 drugs targeting prostate cancer ...

About 2 600 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • Prostate Cancer
  • December 2012
    20 pages
  • Prostate Cancer  

    Cancer  

  • Canada  

View report >

3 Companies for Prostate Cancer

Read our Company Profiles

Management Strategies

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.